Indications for platelet transfusion in children with acute leukemia.
In an attempt ot determine the indications for platelet transfusion in thrombocytopenic patients, we randomized 56 children with acute leukemia to one of two regimens of platelet transfusion. The prophylactic group received platelets when the platelet count fell below 20,000 per mm3 irrespective of clinical events. The therapeutic group was transfused only when significant bleeding occurred and not for thrombocytopenia alone. The time to first bleeding episode was significantly longer and the number of bleeding episodes were significantly reduced in the prophylactic group. The survival curves of the two groups could not be distinguished from each other. Prior to the last month of life, the total number of days on which bleeding was present was significantly reduced by prophylactic therapy. However, in the terminal phase (last month of life), the duration of bleeding episodes was significantly longer in the prophylactic group. This may have been due to a higher incidence of immunologic refractoriness to platelet transfusion. Because of this terminal bleeding, comparison of the two groups for total number of days on which bleeding was present did not show a significant difference over the entire study period.
D000206:Actuarial Analysis; D000208:Acute Disease; D001803:Blood Transfusion; D002490:Central Nervous System / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D006471:Gastrointestinal Hemorrhage / Q000150:complications / Q000628:therapy; D006801:Humans; D007938:Leukemia / Q000097:blood / Q000150:complications / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000097:blood / Q000150:complications / Q000628:therapy; D010976:Platelet Count; D017713:Platelet Transfusion; D011897:Random Allocation; D013921:Thrombocytopenia / Q000097:blood / Q000150:complications / Q000628:therapy; D014566:Urogenital System / Q000503:physiopathology